Related Experiment Video

Updated: Jul 4, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Molecular pathways of programmed cell death in experimental Parkinson's disease

Miquel Vila1, Celine Perier

  • 1Catalan Institution for Research and Advanced Studies, Barcelona, Spain. mvila@it.vhebron.net

Parkinsonism & Related Disorders
|July 4, 2008
PubMed

Insights

Mitochondrial complex I dysfunction triggers Parkinson's disease-like neurodegeneration. Inhibiting the Bax protein significantly reduces dopaminergic neuron death caused by complex I inhibition.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial complex I dysfunction is implicated in Parkinson's disease pathogenesis.
  • This dysfunction activates programmed cell death pathways in dopaminergic neurons.

Purpose of the Study:

  • To investigate the role of Bax in complex I inhibition-induced dopaminergic neurodegeneration.
  • To explore therapeutic strategies targeting Bax to protect neurons.

Main Methods:

  • Utilized complex I inhibition models in dopaminergic neurons.
  • Examined the role of oxidative mechanisms in cytochrome c release.
  • Investigated the impact of targeting Bax transcriptional and post-translational activation.

Main Results:

  • Complex I blockade increases soluble cytochrome c via oxidative stress.
  • Bax activation leads to outer mitochondrial membrane permeabilization and cytochrome c release.
  • Targeting Bax significantly attenuated complex I inhibition-induced cell death.

Conclusions:

  • Bax plays a critical role in mediating neurodegeneration caused by mitochondrial complex I dysfunction.
  • Modulating Bax activity presents a potential therapeutic avenue for Parkinson's disease.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...